The future of medicine: personalised
Prof Hans Lehrach - Max Planck Institute for Molecular Genetics, Berlin, Germany
The future of medicine: personalised ( Prof Hans Lehrach - Max Planck Institute for Molecular Genetics, Berlin, Germany )
2 Jun 2011
Reducing global cancer mortality
Prof Peter Boyle - International Prevention Research Institute, Lyon, France
Reducing global cancer mortality ( Prof Peter Boyle - International Prevention Research Institute, Lyon, France )
2 Jun 2011
The Cancer Genome Atlas (TCGA)
Dr Paul Spellman - National Cancer Institute, Bethesda, USA
The Cancer Genome Atlas (TCGA) ( Dr Paul Spellman - National Cancer Institute, Bethesda, USA )
21 Apr 2011
Combination therapy targeting MEK and PI3K pathways shows anti-tumour activity
Dr Johanna Bendell - Sarah Cannon Research Institute, Nashville, USA
Combination therapy targeting MEK and PI3K pathways shows anti-tumour activity ( Dr Johanna Bendell - Sarah Cannon Research Institute, Nashville, USA )
20 Apr 2011
Ethical considerations surrounding cancer in the elderly and the pros and cons o...
Ian Banks (European Men's Health Forum), Jan Geissler (Leukamie-Online), Ellen V...
Ethical considerations surrounding cancer in the elderly and the pros and cons of web-based resources ( Ian Banks (European Men's Health Forum), Jan Geissler (Leukamie-Online), Ellen Verschuur (Europa Donna) )
17 Mar 2011
Treatment of brain metastases in melanoma patients
Dr Caroline Robert - Institute Gustave Roussy, Paris, France; Prof Alexander Egg...
Treatment of brain metastases in melanoma patients ( Dr Caroline Robert - Institute Gustave Roussy, Paris, France; Prof Alexander Eggermont - Erasmus University of Rotterdam, Netherlands )
7 Feb 2011
Sarah Cannon Research Institute research developments at ASCO 2010
Dr Howard Burris, The Sarah Cannon Research Institute, Nashville
Sarah Cannon Research Institute research developments at ASCO 2010 ( Dr Howard Burris, The Sarah Cannon Research Institute, Nashville )
4 Feb 2011
Clinical benefits and side effects of ipilimumab in melanoma patients
Prof. Giorgio Parmiani - Fondazione San Raffaele del Monte Tabor, Milan, Italy
Clinical benefits and side effects of ipilimumab in melanoma patients ( Prof. Giorgio Parmiani - Fondazione San Raffaele del Monte Tabor, Milan, Italy )
31 Jan 2011
Molecular chaperones: cancer dependence and druggability
Prof Paul Workman - The Institute of Cancer Research, Sutton, UK
Molecular chaperones: cancer dependence and druggability ( Prof Paul Workman - The Institute of Cancer Research, Sutton, UK )
19 Jan 2011
World Health Organisation cancer prevention and control
Dr Andreas Ullrich - World Health Organisation Medical Officer
World Health Organisation cancer prevention and control ( Dr Andreas Ullrich - World Health Organisation Medical Officer )
21 Dec 2010
The European Academy of Cancer Sciences
Prof Alexander Eggermont and Prof Anton Berns
The European Academy of Cancer Sciences ( Prof Alexander Eggermont and Prof Anton Berns )
21 Dec 2010
ESTRO 2010 - Snapshots from the conference
European Society for Therapeutic Radiology and Oncology meeting, Barcelona, 12-1...
ESTRO 2010 - Snapshots from the conference ( European Society for Therapeutic Radiology and Oncology meeting, Barcelona, 12-16th September 2010 )
25 Oct 2010